SCHEMBL1137039

SCHEMBL1137039

O=C(O)c1c(Br)ccnc1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.42
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ASPH Q12797 2/20 0.41
KDM8 Q8N371 2/20 0.41
KDM4A O75164 3/20 0.37
EGLN1 Q9GZT9 2/20 0.37
HIF1AN Q9NWT6 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
RAB9A P51151 1/20 0.37
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA7 P43166 2/20 0.37
CA9 Q16790 2/20 0.37
CA14 Q9ULX7 2/20 0.37
NAPRT Q6XQN6 2/20 0.37
KDM6B O15054 2/20 0.35
KDM5C P41229 2/20 0.35
KDM4C Q9H3R0 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19857476 0.81 KDM4E (0.52) KDM4EALDH1A1SMN1; SMN2ASPHKDM8
SCHEMBL27945025 0.81 KDM4E (0.44) KDM4EALDH1A1SMN1; SMN2ASPHKDM8
SCHEMBL517935 0.79 KDM4E (0.55) KDM4EALDH1A1SMN1; SMN2ASPHKDM8
SCHEMBL7067358 0.78 CA12 (0.50) KDM4EALDH1A1SMN1; SMN2ASPHKDM8
SCHEMBL23830172 0.78 KDM4E (0.41) KDM4EALDH1A1SMN1; SMN2ASPHKDM8
SCHEMBL5249643 0.78 NAPRT (0.46) KDM4EALDH1A1SMN1; SMN2ASPHKDM8
SCHEMBL28589292 0.78 KDM4E (0.53) KDM4EALDH1A1SMN1; SMN2ASPHKDM8
SCHEMBL23971140 0.78 SMN1; SMN2 (0.46) KDM4EALDH1A1SMN1; SMN2ASPHKDM8
SCHEMBL30411449 0.78 SMN1; SMN2 (0.46) KDM4EALDH1A1SMN1; SMN2ASPHKDM8
SCHEMBL10762405 0.75 DPP4 (0.52) KDM4EALDH1A1SMN1; SMN2ASPHKDM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110267953-A Tetrahydroimidazo [4,5-C ] pyridine derivatives as inducers of PD-L1 internalization 因赛特公司 2019-09-20 CN disclosed
EP-1737451-B1 MONOCYCLIC HETEROCYCLES AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-02-23 EP disclosed
CN-1178939-C Non-nucleoside reverse transcriptase inhibitors ���ָ����Ӣ��ķ���ô����޹�˾ 2004-12-08 CN disclosed
CN-1436189-A Non-nucleoside reverse transcriptase inhibitors BOEHRINGER INGELHEIM CA LTD (CA) 2003-08-13 CN disclosed
EP-0225172-A1 Process for the preparation of 5-chloro and 5-bromo-2-hydroxynicotinicacids A.H. ROBINS COMPANY, INCORPORATED (US) 1987-06-10 EP disclosed